Hosted on MSN

Compass Pathways’ Phase III Study on COMP360: A Potential Game-Changer for Depression Treatment

Compass Pathways Plc ((CMPS)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Yahoo Finance

Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder

LONDON & NEW YORK, September 02, 2025--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental ...
Yahoo Finance

Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder

Early and clinically meaningful improvement from baseline in mean CAPS-5 total score (29.5 point reduction at week 12), with change from baseline in mean SDS total score (14.4 point reduction at week ...
Hosted on MSN

Compass Pathways’ Phase III Study on COMP360: A Potential Game-Changer for Treatment-resistant Depression

Compass Pathways Plc ((CMPS)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...